Superworth

Cogent Biosciences EPS COGT

Diluted earnings per share by quarter and over the last twelve months, from 2017.

Last 12 months, to Jun 30, 2026
−$2.23
Latest quarter, Q2 FY26
−$0.52
Fiscal year 2025
−$2.23

Cogent Biosciences' earnings per share was −$2.23 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.52.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$2.23n/a
FY2024−$2.05n/a
FY2023−$2.41n/a
FY2022−$2.45n/a
FY2021−$1.85n/a
FY2020−$12.89n/a
FY2019−$4.18n/a
FY2018−$6.40n/a
FY2017−$10.04n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.52n/a−$2.23
Q1 FY26−$0.53n/a−$2.24
Q4 FY25−$0.68n/a−$2.23
Q3 FY25−$0.50n/a−$2.16
Q2 FY25−$0.53n/a−$2.18
Q1 FY25−$0.52n/a−$2.08
Q4 FY24−$0.61n/a−$2.05
Q3 FY24−$0.52n/a−$2.07
Q2 FY24−$0.43n/a−$2.19
Q1 FY24−$0.49n/a−$2.35
Q4 FY23−$0.63n/a−$2.41
Q3 FY23−$0.64n/a−$2.34

Against its peers

Companies in Drug Manufacturers - General nearest Cogent Biosciences' size, closest first, today.

CompanyEPS, 12 monthsGrowth
COGTCogent Biosciences−$2.23
KNSAKiniksa Pharmaceuticals International$0.97+2325% a year
LGNDLigand Pharmaceuticals$9.40
AMRXAmneal Pharmaceuticals$0.49+4800% a year
INDVIndivior Pharmaceuticals$2.78+227% a year
ALKSAlkermes plc.$0.38−82% a year
ARQTArcutis Biotherapeutics$0.22
LQDALiquidia$1.39
OGNOrganon$0.77−71% a year
TGTXTG Therapeutics$2.74+641% a year
PTGXProtagonist Therapeutics$1.03+47% a year
Peer median$1.00

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Cogent Biosciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.